The Tyro3, AXL, and MerTK (TAM) receptor family regulate tumor-associated macrophages that elicit an immunosuppressive tumor microenvironment, and blockade of TAM receptors via cabozantinib may invigorate antitumor immune activation (47, 48). Here, MERTK is linked to neoplasm.